Cannulas, Collars for Implantable Devices, and Corresponding Systems and Methods

• US 20140262879A1
• Filed: 03/14/2013
• Published: 09/18/2014
• Est. Priority Date: 03/14/2013
• Status: Abandoned Application

• Current Assignee: Cell and Molecular Tissue Engineering, LLC
• Original Assignee: Cell and Molecular Tissue Engineering, LLC
• Inventors: Klueh, Ulrike W., Kreutzer, Donald L.
• Application Number:
  US13/828,212
• Publication Number:
  US 20140262879A1
• Time in Patent Office: Days
• US Class Current: 206/363
• CPC Class Codes: A61B 5/14503 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: Y10T 29/49863 with prestressing of part

Abstract

Disclosed herein is implantable device with a layer of dehydrated basement membrane formed thereon, the implantable device comprising at least one member selected from the group consisting of cannulas, collars for cannulas, and collars for sensors. Methods of making and using the extended use device also are disclosed.

Claims

1. An implantable device with a layer of dehydrated basement membrane formed thereon, the basement membrane layer comprising at least one member selected from the group consisting of sleeve-shaped coatings for cannulas, collars for cannulas, and collars for sensors.

2. The implantable device of claim 1, wherein the basement membrane is dehydrated when in the form of a gel at room temperature.

3. The implantable device of claim 1, wherein the basement membrane is dehydrated at a temperature in the range of 1-15 Dec. C after being placed on the sensor tip when the basement membrane is in the form of a liquid.

4. The implantable device of claim 1, wherein the basement membrane is dehydrated at a temperature in the range of 15-30 Dec. C.

5. The implantable device of claim 1, wherein the basement membrane is applied in multiple layers, and the basement membrane is dehydrated after application of each layer.

6. The implantable device of claim 1, wherein the device also comprises layers of other extracellular matrices formed thereon.

7. The implantable device of claim 1, wherein the basement membrane contains cells and/or factors.

8. The sensor of claim 7, wherein the cells and/or factors are crosslinked to the basement membrane with fibronectin.

9. A kit comprising the implantable device of claim 1 enclosed in sterile packaging.

10. An implantable device having a collar configured to be disposed at an interface between tissue and the implantable device, the collar being formed from an extracellular matrix.

11. The implantable device of claim 10, wherein the extracellular matrix is dehydrated prior to implantation and rehydrated after implantation.

12. The implantable device of claim 10, wherein the collar comprises basement membrane.

13. A kit comprising the implantable device of claim 10 enclosed in sterile, dry packaging, wherein the extracellular matrix is in a dehydrated form.

17. A method of making the implantable device of claim 10.

14. A method comprising:

obtaining an implantable device comprising at least one member selected from the group consisting of cannulas and sensors,

placing basement membrane in the form of a liquid or gel on the implantable device to form at least one of a sleeve and a collar on the device, and

dehydrating the basement membrane on the implantable device.

15. The method of claim 14, further comprising:

inserting the sensor in a biological tissue, and

rehydrating the basement membrane after insertion.

16. The method of claim 16, wherein the basement membrane contains adenovirus vectors containing a VEGF gene.

18. A method of increasing by at least 10 days the lifespan of an implantable device comprising at least one member selected from the group consisting of cannulas and sensors inserted in a mammal, comprising forming an extracellular matrix coating around a portion of the implantable device in the form of a sleeve or a collar, the coating comprising dehydrated extracellular matrix which is rehydrated after implantation, the extracellular matrix having cells and/or factors attached thereto using fibronectin.